Medtronic plc (MDT) operating KPIs
MDTNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends April 24
Financials through Q1 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 3, 2026Score 19/303% below fair value
$96.54−0.57 (-0.59%)
Close on Oct 30, 2026Market cap $123.49BP/E 23.7Yield 2.94%
Medtronic surgical Innovations (Legacy through FY2023Q4) — Worldwide Revenue ($M) ($M)
Reorganized into Surgical & Endoscopy starting FY2024Q1 (with FY2023 comparative restatement).
Latest, Q4 FY23
1,501
Period ended Apr 30, 2023
Change on a year earlier
+0.7%
1,491 in Q4 FY22
History
24 quarters
Since Q2 FY17
Sources
20
Documents cited below
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Breakdown
What makes up surgical innovations (legacy through fy2023q4) — worldwide revenue ($m)
- Surgical Innovations (Legacy through FY2023Q4) — Organic Revenue Growth YoY (%)4.3% · Q4 FY23
- Surgical Innovations (Legacy through FY2023Q4) — Foreign Currency Impact ($M)-54 · Q4 FY23
- Surgical Innovations (Legacy through FY2023Q4) — Reported Revenue Growth YoY (%)0.7% · Q4 FY23
- Surgical Innovations (Legacy through FY2023Q4) — U.S. Revenue ($M)571 · Q4 FY23
Cite this data
StockData. (2026). Medtronic Surgical Innovations (Legacy through FY2023Q4) — Worldwide Revenue ($M) ($M), quarterly Q2 FY17–Q4 FY23 [Data set]. Compiled from Medtronic SEC filings and investor materials. https://stockdatahq.com/stocks/mdt/kpis/ms-si-leg-ww-rev
See every metric in the Medtronic KPI table. Data updated Oct 31, 2026.